PARIS--(BUSINESS WIRE)--Regulatory News: Acticor Biotech (Paris:ALACT), a clinical stage biotechnology company developing an innovative drug for the treatment of cardiovascular emergencies, today ...
SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing and commercializing novel therapies, today ...
After seeing the successes of the likes of Pfizer (PFE) and Moderna (MRNA) in the news practically every day during this second year of the pandemic, the casual observer could be forgiven for assuming ...
A recovering IPO market, surging mergers and acquisitions fuel more biotech venture deals.
Welcome to The TechCrunch Exchange, a weekly startups-and-markets newsletter. It’s inspired by the daily TechCrunch+ column where it gets its name. Want it in your inbox every Saturday? Sign up here.
The Nasdaq Biotechnology Index (NBI™) was launched on Nov. 1, 1993, when the biotech industry was still in its relative infancy and prone to heightened volatility. Ten years later, the index tracked ...
After a turbulent year for biotech, where the public market was down 19% on the year, investor Brad Loncar expects a rebound in 2022, driven by a resurgence in pharma dealmaking. As the CEO of Loncar ...
The biotech industry has been a robust roller-coaster over the last half decade. The State Street SPDR S&P Biotech ETF (NYSE: XBI), which tracks the biotech portion of the S&P 500, started in January ...
Insider has been analyzing how much CEOs and workers in the drug and biotech industries get paid. Using exclusive data from the company-intelligence firm, MyLogIQ, Insider identified the 21 companies ...
It’s been a weird year for biotech stocks. One major index peaked in February, but since then, it’s been a slow downhill trudge for nearly every company. Some of the factors influencing the stock ...
From top left, clockwise: Fred Hutch’s Hilary Hehman; Oregon Venture Fund’s Eric Rosenfeld; Alexandria’s Alice Ly; University of Washington’s François Baneyx; sp3nw’s Michaele Armstrong; and ...
With the rapid growth of the Biotechnology sector, Billy Chau MS '20 is excited to explore the myriad possibilities available in this dynamic industry. As an undergraduate at Brandeis, Billy received ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results